The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -26.46 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -2.60 — no flag raisedOK
- Earnings quality 97/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as NEPHROS INC reports it. History and quarterly detail are in the app.
- Product$18.2M
- Royalty And Other Revenues$555K
- Service$520K
- Other Revenue$24K
- Royalty Revenue$11K
Leadership changes
From NEPHROS INC's own filings, the day they're filed.
- Alisa Lask · Directors · departureeff. 2025-04-23
- Judy Krandel · Chief Financial Officer · appointmenteff. 2023-11-01
- Andrew Astor · Chief Financial Officer · departureeff. 2023-11-01
Latest filings
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-15
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-05-07
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about NEPHROS INC, every answer cited to the official filings🔒
- The Intelligence Brief — added when NEPHROS INC's brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.